Condensed Consolidated Statements of Operations - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Sep. 30, 2015 |
Sep. 30, 2014 |
Sep. 30, 2015 |
Sep. 30, 2014 |
Dec. 31, 2014 |
Dec. 31, 2013 |
|
| Income Statement [Abstract] | ||||||
| REVENUES | ||||||
| OPERATING EXPENSES: | ||||||
| Stock based compensation | $ 256,959 | $ 786,747 | $ 1,534,468 | $ 10,783,948 | $ 11,667,361 | $ 9,877 |
| Selling, general, and administrative expenses | 266,018 | 724,454 | 681,059 | 3,327,010 | 4,014,859 | 2,620,792 |
| Research and development | 216,228 | 357,519 | 352,328 | 921,106 | 1,160,771 | 944,330 |
| Depreciation and amortization | 4,373 | 9,435 | 19,373 | 28,196 | 38,972 | 36,231 |
| Total operating expenses | 743,578 | 1,878,155 | 2,587,228 | 15,060,260 | 16,881,963 | 3,611,230 |
| Loss from operations | (743,578) | $ (1,878,155) | (2,587,228) | (15,060,260) | (16,881,963) | (3,611,230) |
| OTHER INCOME (EXPENSES): | ||||||
| Interest expense | $ (477) | $ (1,619) | (117,042) | $ (118,780) | $ (741,916) | |
| Other expenses | $ (3,069) | (14,585) | ||||
| Interest income | $ 594 | $ 830 | $ 1,762 | $ 3,068 | $ 3,692 | $ 1,211 |
| Other income | $ 48,204 | |||||
| Loss on abandonment of patents | $ (9,340) | |||||
| Gain on sale of assets | $ 95,000 | $ 2,426 | $ 2,426 | 110 | ||
| Total other income (expenses) | $ 117 | $ (2,239) | 143,347 | (126,133) | (112,662) | (749,935) |
| Loss before provision for income taxes | $ (743,461) | $ (1,880,394) | $ (2,443,881) | $ (15,186,393) | $ (16,994,625) | $ (4,361,165) |
| PROVISION FOR INCOME TAXES | ||||||
| NET LOSS | $ (743,461) | $ (1,880,394) | $ (2,443,881) | $ (15,186,393) | $ (16,994,625) | $ (4,361,165) |
| NET LOSS PER SHARE | ||||||
| Basic | $ (0.01) | $ (0.03) | $ (0.04) | $ (0.26) | $ (0.28) | $ (0.13) |
| Diluted | $ (0.01) | $ (0.03) | $ (0.04) | $ (0.26) | $ (0.28) | $ (0.13) |
| SHARES USED IN CALCULATION OF NET INCOME PER SHARE | ||||||
| Basic | 67,955,379 | 63,610,949 | 66,000,101 | 59,019,453 | 60,225,524 | 33,229,093 |
| Diluted | 67,955,379 | 63,610,949 | 66,000,101 | 59,019,453 | 60,225,524 | 33,229,093 |
| X | ||||||||||
- Definition Gain Loss On Abandonment Of Patents. No definition available.
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition This element represents a sum total of expenses not separately reflected on the income statement for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Reflects the sum of all other revenue and income recognized by the entity in the period not otherwise specified in the income statement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|